title: [Current diagnostic and therapy of light chain amyloidosis].
abstract: Amyloidoses are protein-folding disorders in which soluble proteins are deposited as insoluble fibrillar aggregates due to a change in protein conformation. This might occur intra- or extracellularly, systemically or in a localized manner. The light chain type is the most common form of systemic amyloidoses and has the worst prognosis. The underlying disease is a monoclonal, mostly non-malignant plasma cell disorder. The causative treatment is the reduction of the amyloidogenic light chains with conventional or high-dose chemotherapy. Meanwhile, the"new drugs" used in multiple myeloma are also successfully applied. Early diagnosis is important to be able to treat patients effectively and to avoid further deterioration of organ function. Patients with newly diagnosed amyloidosis should be referred to a specialized center for consultation, diagnosis and treatment recommendation.
authors.affiliation: Medizinische Klinik V, Abteilung Hämatologie, Onkologie, Rheumatologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland. stefan.schoenland@med.uni-heidelberg.de
authors.forename: S O
authors.initials: SO
authors.lastname: Schönland
authors.forename: T
authors.initials: T
authors.lastname: Bochtler
authors.forename: A V
authors.initials: AV
authors.lastname: Kristen
authors.forename: A D
authors.initials: AD
authors.lastname: Ho
authors.forename: U
authors.initials: U
authors.lastname: Hegenbart